RecallRadar

FDA Drug recall D-0435-2026

5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit…

On 2026-04-15 the FDA classified a Class II recall of 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit… by Fresenius Kabi Usa, citing lack of Assurance of Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0435-2026
ClassificationClass II
Statusongoing
Initiated2026-03-11
Published2026-04-15
Last updated2026-09-13 11:52 UTC
CompanyFresenius Kabi Usa
DistributionUS

Product

5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60.

Reason

Lack of Assurance of Sterility

Identifiers

ndc65219-456-05
ndc65219-456-60
ndc65219-464-05
ndc65219-464-50
ndc65219-458-05
ndc65219-458-30
ndc65219-460-05
ndc65219-460-20
ndc65219-462-05
ndc65219-462-10
code_infoBatch# 6402296, Exp Date: 07/31/2026.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0435-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.